首页 › 股票 › APUS

APUS — APIMEDS PHARMACEUTICALS US I

申报持仓市值$1.12M
持有基金数(最新)20
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q3 2026)9
机构持仓市值$360.97K · 72.30K 股
新建/增持/减仓/清仓4 / 0 / 5 / 3 · 更新于 2026-11-16
前五大/前十大集中度98.1% / 100.0%
机构整体持仓变动 减持 -88.6% (-332.40K 股)
机构持仓市值变动 下降 -36.7%

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

截至Q3 2026,共 9 家机构在其最新 13F 申报中持有 APUS(APIMEDS PHARMACEUTICALS US I),合计申报市值 $360.97K,对应 72.30K 股。按股数计算较上季度减持 88.6%(-332.40K 股),申报市值环比下降 36.7%。持仓集中度较高:前五大持有人占申报市值的 98.1%,前十大的集中度为 100.0%。

与上一季度相比,4 家新建仓位、5 家减仓、3 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。

APIMEDS PHARMACEUTICALS US I(APUS)的主要机构持有人包括 Yorkville Advisors Global, LP、HRT FINANCIAL LP、Hemenway Trust Co LLC,按 13F 申报市值在本页 20 家持有人中排名居前。

APUS 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 9 72.30K $360.97K -88.6%
Q2 2026 8 461.40K $415.25K -6.8%
Q1 2026 6 448.76K $802.95K +2.8%
Q4 2025 7 395.70K $648.95K +8.3%
Q3 2025 8 399.98K $711.81K +8.8%
Q2 2025 6 278.53K $490.22K —

表内 6 个季度中,机构持股合计减少 74%(Q2 2025 → Q3 2026);单季变动最大的是 Q3 2025(+8.8%)。

前 25 大机构持仓人(Q3 2026) — 9 家基金

基金股数金额组合权重变化
HRT FINANCIAL LP 29.51K $147.00K 0.00% 新进
Hemenway Trust Co LLC 27.40K $137.00K 0.01% 减持
UBS Group AG 6.43K $32.15K 0.00% 减持
VANGUARD CAPITAL MANAGEMENT LLC 5.16K $25.81K 0.00% 减持
VANGUARD FIDUCIARY TRUST CO 2.40K $12.02K 0.00% 减持
Tower Research Capital LLC (TRC) 1.38K $6.91K 0.00% 减持
Ankerstar Wealth, LLC 15 $75 0.00% 新进
Citigroup Inc 1 $5 0.00% 新进
JPMorgan Chase & Co 1 $5 0.00% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 8 家基金

基金股数金额组合权重变化
Hemenway Trust Co LLC 274.00K $246.60K 0.02% 持有
VANGUARD CAPITAL MANAGEMENT LLC 63.65K $57.29K 0.00% 减持
GEODE CAPITAL MANAGEMENT, LLC 35.11K $31.60K 0.00% 新进
Geode Capital Management 35.11K $31.60K 0.00% 减持
VANGUARD FIDUCIARY TRUST CO 24.04K $21.64K 0.00% 持有
JANE STREET GROUP, LLC 15.99K $14.39K 0.00% 新进
UBS Group AG 11.82K $10.64K 0.00% 增持
Tower Research Capital LLC (TRC) 1.66K $1.50K 0.00% 新进

Q1 2026 — 6 家基金

基金股数金额组合权重变化
Hemenway Trust Co LLC 274.00K $490.30K 0.04% 持有
VANGUARD CAPITAL MANAGEMENT LLC 95.93K $171.62K 0.00% 新进
Geode Capital Management 40.05K $71.67K 0.00% 增持
VANGUARD FIDUCIARY TRUST CO 24.04K $43.01K 0.00% 新进
TWO SIGMA SECURITIES, LLC 10.55K $18.88K 0.00% 新进
UBS Group AG 4.19K $7.49K 0.00% 增持

Q4 2025 — 7 家基金

基金股数金额组合权重变化
Hemenway Trust Co LLC 274.00K $449.36K 0.04% 增持
Vanguard Group 58.99K $96.75K 0.00% 持有
Geode Capital Management 34.89K $57.22K 0.00% 增持
JANE STREET GROUP, LLC 27.19K $44.59K 0.00% 新进
UBS Group AG 582 $954 0.00% 新进
Bank of America Corp 40 $66 0.00% 增持
Tower Research Capital LLC (TRC) 10 $16 0.00% 新进

Q3 2025 — 8 家基金

基金股数金额组合权重变化
Hemenway Trust Co LLC 250.00K $445.00K 0.04% 新进
Vanguard Group 58.99K $105.00K 0.00% 新进
Geode Capital Management 30.75K $54.74K 0.00% 新进
Renaissance Technologies 27.89K $49.65K 0.00% 新进
XTX Topco Ltd 18.73K $33.35K 0.00% 新进
HRT FINANCIAL LP 13.57K $24.00K 0.00% 新进
Bank of America Corp 29 $52 0.00% 持有
JPMorgan Chase & Co 8 $14 0.00% 增持

Q2 2025 — 6 家基金

基金股数金额组合权重变化
Yorkville Advisors Global, LP 250.00K $440.00K 0.26% 新进
Citadel Advisors 13.36K $23.51K 0.00% 新进
Goldman Sachs Group 11.99K $21.10K 0.00% 新进
Tower Research Capital LLC (TRC) 3.15K $5.55K 0.00% 新进
Bank of America Corp 29 $52 0.00% 新进
JPMorgan Chase & Co 5 $9 0.00% 新进

新建仓(Q3 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
HRT FINANCIAL LP 29.51K — — — 13.57K —
Hemenway Trust Co LLC 27.40K 274.00K 274.00K 274.00K 250.00K —
UBS Group AG 6.43K 11.82K 4.19K 582 — —
VANGUARD CAPITAL MANAGEMENT LLC 5.16K 63.65K 95.93K — — —
VANGUARD FIDUCIARY TRUST CO 2.40K 24.04K 24.04K — — —
Tower Research Capital LLC (TRC) 1.38K 1.66K — 10 — 3.15K
Ankerstar Wealth, LLC 15 — — — — —
JPMorgan Chase & Co 1 — — — 8 5
Citigroup Inc 1 — — — — —
Yorkville Advisors Global, LP — — — — — 250.00K
Vanguard Group — — — 58.99K 58.99K —
Geode Capital Management — 35.11K 40.05K 34.89K 30.75K —
Renaissance Technologies — — — — 27.89K —
JANE STREET GROUP, LLC — 15.99K — 27.19K — —
XTX Topco Ltd — — — — 18.73K —
GEODE CAPITAL MANAGEMENT, LLC — 35.11K — — — —
Citadel Advisors — — — — — 13.36K
Goldman Sachs Group — — — — — 11.99K
TWO SIGMA SECURITIES, LLC — — 10.55K — — —
Bank of America Corp — — — 40 29 29

下载持有人名单 (CSV)

常见问题

Which funds hold APUS?

As of 2026-Q3, 9 institutional funds reported holding APUS (APIMEDS PHARMACEUTICALS US I) in SEC 13F filings, with a combined reported value of $360.97K.

How many shares of APUS do institutions own?

13F filers reported 72.30K shares of APUS, worth $360.97K in aggregate at the end of 2026-Q3.

Is institutional ownership of APUS rising or falling?

Share counts moved -88.6% versus the prior quarter — distribution.

Who are the top institutional holders of APUS?

The largest 13F holders are Yorkville Advisors Global, LP, HRT FINANCIAL LP, Hemenway Trust Co LLC, Vanguard Group, Renaissance Technologies; the top 25 are ranked at the top of this page.

Who are the major shareholders of APIMEDS PHARMACEUTICALS US I?

The major shareholders of APIMEDS PHARMACEUTICALS US I (APUS) by reported 13F value are Yorkville Advisors Global, LP, HRT FINANCIAL LP, Hemenway Trust Co LLC, Vanguard Group, Renaissance Technologies, among 20 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 APUS」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/APUS/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →